Exa-Cel Therapy ' Transformative ' in SCD, Beta-Thalassemia Exa-Cel Therapy ' Transformative ' in SCD, Beta-Thalassemia

The investigational gene therapy exagamglogene autotemcel shows encouraging efficacy, safety, and patient-reported outcomes for patients with transfusion-dependent beta-thalassemia and sickle cell disease.MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news